Department of Pediatrics, School of Medicine, University of California Davis, Davis, California, USA.
Pediatrics. 2013 Jan;131(1):e73-80. doi: 10.1542/peds.2012-1049. Epub 2012 Dec 10.
Previous studies show that vasogenic cerebral edema (CE) occurs during diabetic ketoacidosis (DKA) treatment in children, but the role of intravenous fluids in contributing to CE is unclear. We used magnetic resonance diffusion weighted imaging to quantify subclinical CE in children with DKA randomized to 2 intravenous fluid regimens.
Children with DKA were randomized to receive fluids at a more rapid rate (n = 8) or a slower rate (n = 10), with all other aspects of DKA treatment kept identical. Children underwent diffusion weighted imaging 3 to 6 hours and 9 to 12 hours after beginning DKA treatment and after recovery from DKA (≥ 72 hours after beginning treatment). We calculated brain apparent diffusion coefficient (ADC) values as the average of measurements in the basal ganglia, thalamus, frontal white matter, and hippocampus and determined the mean brain ADC value during DKA treatment by averaging data from the 3- to 6-hour and 9- to 12-hour measurements. The difference in mean brain ADC between DKA treatment and postrecovery was used as an index of the severity of CE during DKA treatment.
Mean brain ADC values during DKA treatment were significantly higher than postrecovery values, consistent with vasogenic CE (842 ± 38 vs 800 ± 41 × 10(-6) mm(2)/second, P = .002). We did not detect significant differences in ADC elevation in children treated with more rapid versus slower rehydration (β coefficient 0.11 for 1 SD change in ADC, 95% confidence interval: -0.91 to 1.13).
ADC changes during DKA treatment (reflective of vasogenic CE) do not appear to be substantially affected by the rate of intravenous fluid administration.
先前的研究表明,在儿童糖尿病酮症酸中毒(DKA)治疗期间会发生血管源性脑水肿(CE),但静脉输液在导致 CE 中的作用尚不清楚。我们使用磁共振弥散加权成像来定量测定 DKA 患儿的亚临床 CE,这些患儿被随机分为两种静脉输液方案。
DKA 患儿被随机分为快速输液组(n = 8)或慢速输液组(n = 10),DKA 治疗的所有其他方面均保持相同。患儿在开始 DKA 治疗后 3 至 6 小时和 9 至 12 小时以及从 DKA 恢复后(开始治疗后≥72 小时)进行弥散加权成像。我们计算了基底节、丘脑、额叶白质和海马的脑表观弥散系数(ADC)值,并通过对 3 至 6 小时和 9 至 12 小时测量值的平均来确定 DKA 治疗期间的平均脑 ADC 值。DKA 治疗期间和恢复后的平均脑 ADC 值之间的差异用作 DKA 治疗期间 CE 严重程度的指标。
DKA 治疗期间的平均脑 ADC 值明显高于恢复后的 ADC 值,与血管源性 CE 一致(842 ± 38 对 800 ± 41×10(-6)mm(2)/秒,P =.002)。我们没有发现快速补液组和慢速补液组之间 ADC 升高的差异(ADC 升高 1 个标准差的β系数为 0.11,95%置信区间:-0.91 至 1.13)。
DKA 治疗期间的 ADC 变化(反映血管源性 CE)似乎不会受到静脉输液速度的显著影响。